| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = -$71,108 ) |
| | 2022 | 2017 | STC BIOLOGICS, INC. | 763D CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R01AI116593 | The Role of IgE in Human Schistosomiasis | 000 | 3 | NIH | 9/12/2022 | -$71,108 |
|
| Issue Date FY: 2018 ( Subtotal = $0 ) |
| | 2018 | 2017 | STC BIOLOGICS, INC. | 763D CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R01AI116593 | The Role of IgE in Human Schistosomiasis | 001 | 3 | NIH | 3/13/2018 | $0 |
| | 2018 | 2015 | STC BIOLOGICS, INC. | 763D CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R43CA186422 | A Multi-Targeting Ligand Trap to Overcome resistance in BRAF Mutant Colorectal Cancer | 000 | 1 | NIH | 1/30/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $181,108 ) |
| | 2017 | 2017 | STC BIOLOGICS, INC. | 763D CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R01AI116593 | The Role of IgE in Human Schistosomiasis | 001 | 3 | NIH | 7/13/2017 | -$410,577 |
| | 2017 | 2017 | STC BIOLOGICS, INC. | 763D CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R01AI116593 | The Role of IgE in Human Schistosomiasis | 000 | 3 | NIH | 1/19/2017 | $591,685 |
|
| Issue Date FY: 2016 ( Subtotal = $569,904 ) |
| | 2016 | 2016 | STC BIOLOGICS, INC. | 763 D CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R01AI116593 | The Role of IgE in Human Schistosomiasis | 000 | 2 | NIH | 1/13/2016 | $569,904 |
|
| Issue Date FY: 2015 ( Subtotal = $867,308 ) |
| | 2015 | 2015 | STC BIOLOGICS, INC. | 763 D CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R01AI116593 | The Role of IgE in Human Schistosomiasis | 000 | 1 | NIH | 2/10/2015 | $567,308 |
| | 2015 | 2015 | STC BIOLOGICS, INC. | 763 D CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R43CA186422 | A Multi-Targeting Ligand Trap to Overcome resistance in BRAF Mutant Colorectal Cancer | 000 | 1 | NIH | 6/15/2015 | $300,000 |
|
|
